TargImmune Therapeutics AG is a startup company established in March 2016 in Basel, Switzerland. TargImmune is developing a novel cancer-targeted platform technology CTPIC in the field of immuno-oncology and personalized therapy.
iOncologi, a Florida-based clinical-stage company focused on advancing immunotherapy platform technologies, has acquired TargImmune Therapeutics.
Building | F |
---|---|
Industry | Biotech |
Research Topics | Oncology |
Employees | 9 |
Founding year | 2016 |